An epigenomic approach to therapy for tamoxifen-resistant breast cancerQin Feng, Bert W. O’Malley, Zheng Zhang et al.|Cell Research|2014Cited by 188
FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancerXiaoyong Fu, Rachel Schiff, Rinath Jeselsohn et al.|Proceedings of the National Academy of Sciences|2016Cited by 185
The changing role of ER in endocrine resistanceAgostina Nardone, Rachel Schiff, Carmine De Angelis et al.|The Breast|2015Cited by 133
Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 TherapyMario Giuliano, Rachel Schiff, Huizhong Hu et al.|Clinical Cancer Research|2015Cited by 119
Pathway-Centric Integrative Analysis Identifies RRM2 as a Prognostic Marker in Breast Cancer Associated with Poor Survival and Tamoxifen ResistanceNagireddy Putluri, Arun Sreekumar, Suman Kumar Maity et al.|Neoplasia|2014Cited by 90